Items where Author is "Xu, K."

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Date | Item Type | Refereed
Jump to: 2021 | 2015
Number of items: 2.


Chen, Y. and Xu, K. and Piccoli, L. and Foglierini, M. and Tan, J. and Jin, W. and Gorman, J. and Tsybovsky, Y. and Zhang, B. and Traore, B. and Silacci-Fregni, C. and Daubenberger, C. and Crompton, P. D. and Geiger, R. and Sallusto, F. and Kwong, P. D. and Lanzavecchia, A.. (2021) Structural basis of malaria RIFIN binding by LILRB1-containing antibodies. Nature (592). pp. 639-643.


Meyer, S. C. and Keller, M. D. and Chiu, S. and Koppikar, P. and Guryanova, O. A. and Rapaport, F. and Xu, K. and Manova, K. and Pankov, D. and O'Reilly, R. J. and Kleppe, M. and McKenney, A. S. and Shih, A. H. and Shank, K. and Ahn, J. and Papalexi, E. and Spitzer, B. and Socci, N. and Viale, A. and Mandon, E. and Ebel, N. and Andraos, R. and Rubert, J. and Dammassa, E. and Romanet, V. and Dolemeyer, A. and Zender, M. and Heinlein, M. and Rampal, R. and Weinberg, R. S. and Hoffman, R. and Sellers, W. R. and Hofmann, F. and Murakami, M. and Baffert, F. and Gaul, C. and Radimerski, T. and Levine, R. L.. (2015) CHZ868, a Type II JAK2 Inhibitor, Reverses Type I JAK Inhibitor Persistence and Demonstrates Efficacy in Myeloproliferative Neoplasms. Cancer Cell, 28 (1). pp. 15-28.

This list was generated on Sat Apr 1 00:32:29 2023 CEST.